CRO/Sponsor Articles

Applied Clinical Trials: Feb 19, 2015
Recent advances in proteomics, genomics and metabolomics have enabled us to understand the molecular basis of disease at both the diagnostic and treatment levels.
Applied Clinical Trials: Jan 22, 2015
Over recent years global drug companies large or small have recognized that one root cause of the high failure rate in their clinical development lies in the selection of right therapeutic targets.
Applied Clinical Trials: Sep 30, 2014
Exploring sourcing model options for appropriate incorporation of DMCs into a clinical program.
Applied Clinical Trials: Sep 10, 2014
Why do we audit our suppliers and what do we hope to achieve when we do?
Applied Clinical Trials: Aug 19, 2014
Implementing a "just-in-time" site activation process effectively can significantly speed trial startup.
Applied Clinical Trials: Jul 06, 2014
The costs of drug development are increasing, driven in large part by increasing failure rates in all phases of clinical development.
Applied Clinical Trials: Jun 25, 2014
PCORI underscored existing trends toward increasingly individualized and personalized medical care...
Applied Clinical Trials: Jun 23, 2014
Pharmacovigilance is the next frontier for outsourcing in the pharmaceutical and biologics industry.
Applied Clinical Trials: May 31, 2014
A two-phase statistical analysis identifies the key performance drivers in clinical trial startup.
Company News Release: Apr 22, 2014
By Applied Clinical Trials
In December 2013, Sanofi opened its submissions for the second challenge in its Partners in Patient Health

CRO/Sponsor News

ERT to Acquire PHT Corporation

ERT, a leading global solution provider for high- quality patient safety and efficacy endpoint data collection, and PHT Corporation (PHT), the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research, announced today that they have signed a definitive agreement under which ERT will acquire PHT.

ACRES Launches First Phase of Shared Clinical Research Platform

The Alliance for Clinical Research Excellence and Safety (ACRES) announced the launch of ACRES BlueCloud™

Management buy-out goes ahead at Synexus

The deal will enable Synexus to further expand both its global network of clinical research centers - into the US, Asia and South America - and the range of therapy areas it focuses on.

DrugDev Selected for TransCelerate's Investigator Registry

TransCelerate BioPharma Inc. has selected DrugDev to develop and host its Investigator Registry

PAREXEL Continues Expansion of Site Alliance Network

Global network accelerates patient recruitment and clinical trial start-up times